Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines

被引:38
作者
Wright, SW
Hageman, DL
McClure, LD
Carlo, AA
Treadway, JL
Mathiowetz, AM
Withka, JM
Bauer, PH
机构
[1] Pfizer Inc, Cent Res, Groton, CT 06340 USA
[2] Pfizer Discovery Technol Ctr, Cambridge, MA 02139 USA
关键词
D O I
10.1016/S0960-894X(00)00586-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Anilinoquinazolines currently of interest as inhibitors of tyrosine kinases have been found to be allosteric inhibitors of the enzyme fructose 1,6-bisphosphatase. These represent a new approach to inhibition of F16BPase and serve as leads for further drug design. Enzyme inhibition is achieved by binding at an unidentified allosteric site. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 35 条
[21]   HORMONAL-REGULATION OF HEPATIC GLUCONEOGENESIS AND GLYCOLYSIS [J].
PILKIS, SJ ;
ELMAGHRABI, MR ;
CLAUS, TH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :755-783
[22]  
PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.physiol.54.1.885
[23]  
PONTREMO.S, 1965, J BIOL CHEM, V240, P3459
[24]   FRUCTOSE DIPHOSPHATASE FROM RABBIT LIVER .X. ISOLATION AND KINETIC PROPERTIES OF ENZYME-ADENOSINE MONOPHOSPHATE COMPLEX [J].
PONTREMOLI, S ;
GRAZI, E ;
ACCORSI, A .
BIOCHEMISTRY, 1968, 7 (10) :3628-+
[25]   Tyrosine kinase inhibitors .12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor [J].
Rewcastle, GW ;
Bridges, AJ ;
Fry, DW ;
Rubin, JR ;
Denny, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) :1820-1826
[26]   TYROSINE KINASE INHIBITORS .5. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS FOR 4-[(PHENYLMETHYL)AMINO]-QUINAZOLINES AND 4-(PHENYLAMINO)QUINAZOLINES AS POTENT ADENOSINE 5'-TRIPHOSPHATE BINDING-SITE INHIBITORS OF THE TYROSINE KINASE DOMAIN OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
REWCASTLE, GW ;
DENNY, WA ;
BRIDGES, AJ ;
ZHOU, HR ;
CODY, DR ;
MCMICHAEL, A ;
FRY, DW .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (18) :3482-3487
[27]  
Schnur R. C., 1998, U.S. Pat., Patent No. [5747498, 5,747,498]
[28]  
SUGIYAMA Y, 1989, ENDOCRINOL JAPON, V36, P65
[29]  
TAKETA K, 1965, J BIOL CHEM, V240, P651
[30]  
VANSCHAFTINGEN E, 1981, P NATL ACAD SCI USA, V78, P2862